-

DIVERSIFIED HEALTHCARE INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Diversified Healthcare Trust - DHC

NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Diversified Healthcare Trust (NasdaqGS: DHC) to Office Properties Income Trust (NasdaqGS: OPI). Under the terms of the proposed transaction, shareholders of Diversified will receive 0.147 shares of OPI for each share of Diversified that they own. KSF is seeking to determine whether this consideration and the process that led to it are adequate, or whether the consideration undervalues the Company.

If you believe that this transaction undervalues the Company and/or if you would like to discuss your legal rights regarding the proposed sale, you may, without obligation or cost to you, e-mail or call KSF Managing Partner Lewis S. Kahn (lewis.kahn@ksfcounsel.com) toll free at any time at 855-768-1857, or visit https://www.ksfcounsel.com/cases/nasdaqgs-dhc/ to learn more.

To learn more about KSF, whose partners include the Former Louisiana Attorney General, visit www.ksfcounsel.com.

Contacts

Kahn Swick & Foti, LLC
Lewis S. Kahn, KSF Managing Partner
855-768-1857
lewis.kahn@ksfcounsel.com

Industry:

Kahn Swick & Foti, LLC

NASDAQ:DHC
Release Versions
English

Contacts

Kahn Swick & Foti, LLC
Lewis S. Kahn, KSF Managing Partner
855-768-1857
lewis.kahn@ksfcounsel.com

More News From Kahn Swick & Foti, LLC

Humacyte Investigation Initiated: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Humacyte, Inc. - HUMA

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at the law firm of Kahn Swick & Foti, LLC (“KSF”), announces that KSF has commenced an investigation into Humacyte, Inc. (NasdaqGS: HUMA) (“Humacyte” or the “Company”). On August 9, 2024, the company announced that the Food and Drug Administration (“FDA”) “will require additional time to complete its review of its Biologic License Application (BLA) for the acellular tiss...

Kyndryl 72 Hour Deadline Alert: Kahn Swick & Foti, LLC Remind Investors With Losses In Excess Of $100,000 of Deadline in Class Action Lawsuits Against Kyndryl Holdings, Inc. - KD

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, the former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until April 13, 2026 to file lead plaintiff applications in securities class action lawsuits against Kyndryl Holdings, Inc. (“Kyndryl” or the “Company”) (NYSE: KD), if they purchased or otherwise acquired the Company’s securities between August 1, 2024 and February 9, 2026, inclusive (the “Class Period”). Thes...

Enviri Corporation Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Enviri Corporation - NVRI

NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti, LLC (“KSF”) are investigating the proposed sale of Enviri Corporation’s (NYSE: NVRI) Clean Earth to Veolia Environnement SA. Under the terms of the proposed transaction, shareholders of Enviri will receive cash consideration of $14.50 - $16.50 for each share of Enviri that they own. KSF is seeking to determine whether this consideration and the proce...
Back to Newsroom